Positron Corp. (POSC.OB) Joins Forces with Disease Management, LLC on Development Project
Read the full article: http://blog.qualitystocks.net/?p=10786
Positron Corp. is a cardiac health solutions company engaged in radiopharmeceutical development and the advancement of current internal imaging technologies. The radiopharmeceutical sector of American nuclear cardiology is a $1.2 billion dollar industry, and Positron Corp. has now teamed up with Disease Management, LLC, to increase its market share.
Vested Interest:
The author does not own shares in POSC- Login or register to post comments
- Email this page
Related Articles
- Del Global Technologies Corp. (DGTC.OB) Completes Another Successful Imaging Installation
- Molecular Insight Pharmaceuticals, Inc. (MIPI) CEO Presents at Healthcare Conference
- 3DIcon Corp. (TDCP.OB) Praised For New 3D Imaging Technology
- Chembio Diagnostics, Inc. (CEMI.OB) Reports Strong Third Quarter Results
- Medical Connections Holdings, Inc. (MCTH.OB) Reports 58% Revenue Increase